Text Size

Evaluation of Osseo-integration After Placement of Dental Implants With Patients Receiving Radiotherapy for Buccopharyngeal Oncology

This study is currently recruiting participants.
Verified January 2013 by University Hospital, Ghent
Sponsor:
Information provided by (Responsible Party):
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT00313989
First received: April 11, 2006
Last updated: January 29, 2013
Last verified: January 2013
History of Changes
  Purpose

Follow up of implants with patients receiving radiotherapy for buccopharyngeal oncology. Implants will be placed 6 weeks before start of the radiotherapy or at least 3 months after the end of the radiotherapy


Condition Intervention
Dental Implants
 Procedure: Evaluation of the success rate of implants

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Evaluation of Osseo-integration After Placement of Dental Implants With Patients Receiving Radiotherapy for Buccopharyngeal Oncology

Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:
  • Recovering and ingrowing of dental implants [ Time Frame: 4 to 6 months ] [ Designated as safety issue: No ]
  • Success rate of dental implants [ Time Frame: 4 to 6 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 200
Study Start Date: September 2007
Estimated Study Completion Date: August 2013
Estimated Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Evaluation of implants of patients receiving radiotherapy. Procedure: Evaluation of the success rate of implants
Evaluation of the success rate of implants

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients receiving radiotherapy (6 weeks later or at least 3 months before) for buccopharyngeal oncology
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00313989

Contacts
Contact: Hugo De Bruyn, MD, PhD + 32 9 332.40.18 hugo.debruyn@UGent.be

Locations
Belgium
University Hospital Ghent Recruiting
Ghent, Belgium, 9000
Contact: Hugo De Bruyn, MD, PhD     + 32 9 332.40.18     hugo.debruyn@UGent.be    
Principal Investigator: Hugo De Bruyn, MD, PhD            
Sponsors and Collaborators
University Hospital, Ghent
Investigators
Principal Investigator: Hugo De Bruyn, MD, PhD University Hospital, Ghent
  More Information

Additional Information:
Website University Hospital Ghent  This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party: University Hospital, Ghent
ClinicalTrials.gov Identifier: NCT00313989     History of Changes
Other Study ID Numbers: 2006/125
Study First Received: April 11, 2006
Last Updated: January 29, 2013
Health Authority: Belgium: Institutional Review Board

ClinicalTrials.gov processed this record on June 18, 2013